Curated industry news, with links to every original source. My own selections are marked.
Choose a subject above to focus these stories.
"This medicine could be one of our largest medicines in history," Novartis CEO Vas Narasimhan told CNBC on Tuesday, as the Swiss drugmaker backed remibrutinib, its experimental MS medicine, to… Excerpt from CNBC.
Marketing agencies across the ad industry have been enthusiastic adopters of AI agents. Excerpt from Digiday.
(Keystone-SDA) Der Bund ändert mit der Reform Efas die Finanzierung des Gesundheitswesens: Ab 2028 sollen Kantone und Krankenkassen ambulante und stationäre Leistungen einheitlich finanzieren. Excerpt from Swissinfo.
Perrigo sells infant formula business to MeridianMade in deal worth up to US$175M Abbott to spin off US$8.5B Nutrition business behind Ensure and Similac Perrigo has agreed to sell its Infant Formula… Excerpt from Nutrition Insight.
Starbucks Corp. Chief Executive Officer Brian Niccol said building a multi-brand company is a possibility, weeks after the chain shut down rumors that it was exploring a takeover of Chipotle Mexican… Excerpt from Bloomberg.
Teva acquires BioXcel’s BXCL501, under FDA review for at-home agitation use; Rumi Therapeutics gains an option on Enthorin’s Fragile X PDE2 inhibitor. Excerpt from Pharmaceutical Executive.
Intuitively, Amazon is putting AI at the center of its advertising business, previewing the consolidation of previously separate buying tools into a single platform that gives its technology greater… Excerpt from Digiday.
Im Jahr 2025 verabschiedete das Gremium ein Paket, bestehend aus zwölf Massnahmen zur Kostendämpfung im Gesundheitswesen. 300 Millionen Franken sollen damit gespart werden. Excerpt from NZZ.
Joël Hoffmann vom Kantonsspital Aarau, Claude Kaufmann von Hirslanden und Marcel Schlatter vom USZ sind die besten Kommunikationsleute der Schweizer Spitäler. Excerpt from Medinside.
234 Millionen Franken flossen so im vergangenen Jahr in der Schweiz für Sponsoring und Kooperationen ans Gesundheitswesen oder an Fachorganisationen der Branche – rund 11 Prozent weniger als im… Excerpt from Bilanz.
A roundup of this week's biggest marketing leadership moves She’ll oversee the Unilever brand’s marketing, creative, and consumer teams, blending its “science-backed foundation with modern,… Excerpt from Adweek.
Swiss firm Novartis ranks second with CHF26.4 million, followed by Roche, which contributes CHF25.6 million. Excerpt from Swissinfo.
Food Supplements Europe (FSE) has issued new guidelines urging brands and social media influencers to tackle misleading food supplement claims and ensure promotional content complies with EU consumer… Excerpt from NutraIngredients.
Eingriffe am System sollen die Kosten für Gesundheitsleistungen dämpfen. Sechs Massnahmen sollen ab 2027 umgesetzt werden. Excerpt from cash.
Transforming With AI Requires More Than Tools: The Rise Of The Enterprise AI Operating Model Now, the challenge for companies is for this adoption to truly reflect financial results. One of the most… Excerpt from Forbes.
Finding new opportunities beyond cost savings In advertising, our industry is moving faster than most: more than two-thirds of ad buyers utilize agents for buying and campaign execution. Excerpt from Adweek.
Das Medizinprodukt der höchsten Risikoklasse hatte 2016 keine CE-Zertifizierung. Es war für die rechte Herzklappe noch nie am Menschen getestet worden. Excerpt from SRF.
OpenArt leaders explain how removing production friction lets marketers scale campaigns tenfold Two years ago, AI-generated video was a punchline. Excerpt from Adweek.
Source Global Research, which tracks the consulting market, found that the share of clients who had paid for AI-related consulting in the prior 12 months rose from 81% in the second quarter of 2026… Excerpt from Forbes.
The Court of Justice of the European Union (CJEU) has further clarified the requirements governing health claims in the marketing of food supplements (CJEU, judgment of 17 September 2026 – C-721/24). Excerpt from MTR Legal.
Spending on artificial intelligence has roughly doubled in under a year, yet fewer than four in ten companies can attribute any profit impact to it. Excerpt from Forbes.
No top stories on this subject today.
Explore career opportunities in Swiss pharma and life sciences.
I write about Swiss pharma and healthcare, consumer healthcare, marketing, business strategy and meaningful innovation, and I follow what is changing in these fields through a curated news desk.